Guardant Health and Parker Institute for Cancer Immunotherapy (PICI) launch research collaboration to study connection between cancer biomarkers and immunotherapy treatment response

PALO ALTO, Calif., & SAN FRANCISCO–(BUSINESS WIRE)–Guardant Health and Parker ICI will study the correlation between molecular cancer biomarkers and patient response to immunotherapy treatment.